← Back to Search

Protect Your Colon™ Decision Aid for Colorectal Cancer Screening

N/A

Recruiting

Led By Christopher V Almario, MD, MSHPM

Research Sponsored by Cedars-Sinai Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months post visit

Awards & highlights

No Placebo-Only Group

Summary

This trial will examine how a decision aid, Protect Your Colon™, affects patients' decisions about colorectal cancer screening. It may lead to more people getting tested and increase screening uptake.

Who is the study for?

This trial is for individuals aged 45 to 75 who have never been screened for colorectal cancer (CRC) and are not at high risk due to conditions like inflammatory bowel disease or family history of CRC.

What is being tested?

The trial is testing 'Protect Your Colon™', a decision aid designed to help patients choose the most suitable CRC screening test based on their values, with the goal of increasing overall screening rates.

What are the potential side effects?

Since 'Protect Your Colon™' is an informational tool rather than a medical treatment, it does not have physical side effects. The focus is on improving communication and informed decision-making.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months post visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months post visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Rate of completion of a CRC screening test

Secondary study objectives

Qualitative feedback on details of CRC screening test

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Protect Your Colon™ (Intervention)Experimental Treatment1 Intervention

Patients randomized to Protect Your Colon™ will be directed to go through the website at least 2 days before their clinic appointment. Those who finish the decision aid will then review their personalized report which details their priorities in selecting a screening test as well as the test that best matches their values. Patients will also be encouraged to bring their personalized report with them to the visit to discuss with their doctor. All intervention participants will also receive a reminder via email one day before their scheduled clinic visit. They will be reminded to go through the Protect Your Colon™ website before the clinic visit and to bring their personalized report with them to the visit.

Group II: Usual Care (Control)Active Control1 Intervention

The usual care group will be managed according to the providers' customary practices: CRC screening discussions, if any, are at the discretion of the provider as Cedars-Sinai does not employ a standardized approach. Patients randomized to the control arm will not be sent any materials before their clinic appointment.

Do I qualify?Apply below to find out